BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19910536)

  • 1. Impact of diastolic dysfunction on the development of heart failure in diabetic patients after acute myocardial infarction.
    Aronson D; Musallam A; Lessick J; Dabbah S; Carasso S; Hammerman H; Reisner S; Agmon Y; Mutlak D
    Circ Heart Fail; 2010 Jan; 3(1):125-31. PubMed ID: 19910536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
    Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive filling pattern is a powerful predictor of heart failure events postacute myocardial infarction and in established heart failure: a literature-based meta-analysis.
    Somaratne JB; Whalley GA; Gamble GD; Doughty RN
    J Card Fail; 2007 Jun; 13(5):346-52. PubMed ID: 17602980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of restrictive diastolic filling associated with heart failure: a meta-analysis.
    Whalley GA; Gamble GD; Doughty RN
    Int J Cardiol; 2007 Mar; 116(1):70-7. PubMed ID: 16901562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
    Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual patient meta-analyses of restrictive diastolic filling pattern and mortality in patients post acute myocardial infarction and in patients with chronic heart failure.
    Whalley GA; Gamble GD; Dini FL; Klein AL; Møller JE; Quintana M; Yu CM; Doughty RN;
    Int J Cardiol; 2007 Nov; 122(3):207-15. PubMed ID: 17321616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
    Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between diabetic and non-diabetic hypertensive patients with first acute non-ST elevation myocardial infarction and predictors of in-hospital complications.
    Colivicchi F; Mettimano M; Genovesi-Ebert A; Schinzari F; Iantorno M; Melina G; Santini M; Cardillo C; Melina D
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):267-72. PubMed ID: 18301144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of left ventricular diastolic dysfunction as a predictor of one-year rehospitalization in survivors of acute myocardial infarction.
    Khumri TM; Reid KJ; Kosiborod M; Spertus JA; Main ML
    Am J Cardiol; 2009 Jan; 103(1):17-21. PubMed ID: 19101223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
    Lewis EF; Velazquez EJ; Solomon SD; Hellkamp AS; McMurray JJ; Mathias J; Rouleau JL; Maggioni AP; Swedberg K; Kober L; White H; Dalby AJ; Francis GS; Zannad F; Califf RM; Pfeffer MA
    Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction.
    Parissis JT; Adamopoulos S; Venetsanou K; Kostakis G; Rigas A; Karas SM; Kremastinos D
    Eur Cytokine Netw; 2004; 15(2):139-44. PubMed ID: 15319174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure after acute coronary syndrome: identify to treat better!
    Rocha S; Nabais S; Magalhães S; Salgado A; Azevedo P; Torres M; Marques J; Pereira MA; Correia A
    Rev Port Cardiol; 2007 Apr; 26(4):349-59. PubMed ID: 17695730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).
    Steg PG; Dabbous OH; Feldman LJ; Cohen-Solal A; Aumont MC; López-Sendón J; Budaj A; Goldberg RJ; Klein W; Anderson FA;
    Circulation; 2004 Feb; 109(4):494-9. PubMed ID: 14744970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
    Thomas KL; Al-Khatib SM; Lokhnygina Y; Solomon SD; Kober L; McMurray JJ; Califf RM; Velazquez EJ
    Am Heart J; 2008 Jan; 155(1):87-93. PubMed ID: 18082495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.